Sandu Pharmaceuticals Ltd — Important, 15-08-2025: Company Update

Sandu Pharmaceuticals has published its financial results for the quarter ended June 30, 2025. Total income from operations stood at ₹16.72 crore, a slight dip from ₹17.09 crore in the same period last year. Despite this, net profit after tax saw a healthy increase to ₹0.22 crore, up from ₹0.17 crore year-over-year. The company also strengthened its financial position, with reserves growing to ₹24.10 crore compared to ₹22.58 crore previously. Basic and diluted earnings per share improved to ₹0.23 from ₹0.17, signaling a positive trend in profitability.